Dominance of Multidrug-Resistant Denmark 14 -32 (ST230) Clone Among Streptococcus pneumoniae Serotype 19A Isolates Causing Pneumococcal Disease in Bulgaria from 1992 to 2013
Restricted accessResearch articleFirst published online February, 2015
Dominance of Multidrug-Resistant Denmark 14 -32 (ST230) Clone Among Streptococcus pneumoniae Serotype 19A Isolates Causing Pneumococcal Disease in Bulgaria from 1992 to 2013
A pneumococcal conjugate vaccine (PCV10) was introduced in Bulgarian national immunization program since April 2010. Clonal composition based on pulsed-field gel electrophoresis and multilocus sequence typing genotyping of 52 serotype 19A Streptococcus pneumoniae isolates was analyzed. These were invasive and respiratory isolates collected between 1992 and 2013 from both children (78.8% <5 years) and adults with pneumococcal infections. Multidrug resistance was found in 82.7% of all 19A isolates. The most prevalent genotype (63.5%) among serotype 19A pneumococcal strains was the multidrug-resistant clonal complex CC230, which is a capsular switched variant of the Denmark14-32 (ST230) global clone. The most frequent sequence type (ST) was ST230 (48.1%) and together with four other closely related STs (15.4%), belonging to ST1611, ST276, ST7466, and ST2013, which were single- and double-locus variants; they were included in the main CC230. The disappearance of highly drug-resistant ST663 clone and emergence of new clones as CC320 and CC199 was also observed among the rest 19A isolates. A comparison of clonal composition between invasive and noninvasive isolates did not show a great genetic diversity among both kinds of isolates. Continuous surveillance of serotype 19A population following the introduction of PCV10 is essential to evaluate the impact of the vaccine on the epidemiology of this serotype.
Get full access to this article
View all access options for this article.
References
1.
AguiarI.S., PintoF.R., NunesS., SerranoI., Melo-CristinoJ., Sá-LeãoR., RamirezM., and de LencastreH.. 2010. Denmark14-230 clone as an increasing cause of pneumococcal infection in Portugal within a background of diverse serotype 19A lineages. J. Clin. Microbiol., 48:101–108.
2.
ArdanuyC., RoloD., FenollA., TarragoD., CalatayudL., and LiñaresJ.2009. Emergence of a multidrug-resistant clone (ST320) among invasive serotype 19A pneumococci in Spain. J. Antimicrob. Chemother., 64:507–510.
3.
BeallB.W., GertzR.E., HulkowerR.L., WhineyC.G., MooreM.R., and BrueggemannA.B.. 2011. Shifting genetic structure of invasive serotype 19A pneumococci in the United States. J. Infect. Dis., 203:1360–1368.
4.
BogaertD., De GrootR., and HermansP.W.2004. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect. Dis., 4:144–154.
5.
CarriçoJ.A., Silva-CostaC., Melo-CristinoJ., PintoF.R., de LencastreH., AlmeidaJ.S., and RamirezM.. J. Clin. Microbiol., 44:2524–2532.
6.
[CDC] Centers for Disease Control and Prevention. 2005. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease—United States, 1998–2003. MMWR Morb. Mortal. Wkly. Rep., 54:893–897.
7.
[CLSI] Clinical and Laboratory Standards Institute. 2013. Performance standards for antimicrobial susceptibility testing, 23th ed. Approved standard M100–S23. CLSI, Wayne, PA.
8.
DaganR., Givon-LaviN., LeibovitzE., GreenbergD., and PoratN.2009. Introduction and proliferation of multidrug-resistant Streptococcus pneumoniae serotype 19A clones that cause acute otitis media in an unvaccinated population. J. Infect. Dis., 199:776–785.
9.
EnrightM.C., and SprattB.G.. 1998. A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Microbiology, 144:3049–3060.
10.
FeilE.J., LiB.C., AanensenD.M., HanageW.P., and SprattB.G.. 2004. eBURST: Inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data. J. Bacteriol., 186:1518–1530.
11.
HanageW.P., BishopC.J., LeeG.M., LipsitchM., StevensonA., Rifas-ShimanS.L., PeltonS.I., HuangS.S., and FinkelsteinJ.A.. 2011. Clonal replacement among 19A Streptococcus pneumoniae in Massachusetts, prior to 13 valent conjugate vaccination. Vaccine, 29:8877–8881.
12.
HausdorffW.P., HoetB., and SchuermanL.. 2010. Do pneumococcal conjugate vaccines provide any cross-protection against serotype 19A?. BMC Pediatr., 10:4.
13.
Mahioub-MessaiF., DoitC., KoeckJ.L., BillardT., EvrardB., BidetP., HubansC., RaymondJ., LevyC., Robert CohenR., and BingenE.. 2009. Population snapshot of Streptococcus pneumoniae serotype 19A isolates before and after the introduction of 7-valent pneumococcal vaccination in French children. J. Clin. Microbiol., 47:837–840.
14.
MarimonJ.M., AlonsoM., RoloD., ArdanuyC., LiñaresJ., and Pérez-TralleroE.. 2012. Molecular characterization of Streptococcus pneumoniae invasive serotype 19A isolates from adults in two Spanish regions (1994–2009). Eur. J. Clin. Microbiol. Infect. Dis., 31:1009–1031.
15.
MontanariM.P., MingoiaM., GiovanettiE., and VaraldoP.E.. 2003. Phenotypes and genotypes of erythromycin-resistant pneumococci in Italy. J. Clin. Microbiol., 41:428–431.
16.
ReinertR., JacobsM.R., and KaplanS.L.2010. Pneumococcal disease caused by serotype 19A: review of the literature and implications for future vaccine development. Vaccine, 28:4249–4259.
17.
SetchanovaL., AlexandrovaA., MitovI., NashevD., KantardjievT., and The Group for Microbiological surveillance of pneumococci. 2012. Serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in bulgaria before the introduction of pneumococcal conjugate vaccine. J. Chemother., 24:12–17.
18.
SetchanovaL., KostyanevT., AlexandrovaA., MitovI., NashevD., and KantardjievT.2013. Microbiological characterization of Streptococcus pneumoniae and non-typeable Haemophilus influenzae isolates as primary causes of acute otitis media in Bulgarian children before the introduction of conjugate vaccines. Ann. Clin. Microbiol. Antimicrob., 12:6.
19.
SetchanovaL., and TomaszA.1999. Molecular characterization of penicillin-resistant Streptococcus pneumoniae isolates from Bulgaria. J. Clin. Microbiol., 37:638–648.
20.
ShinJ., BaekJ.Y., KimS.H., SongJ.H., and KoK.S.. 2011. Predominance of ST320 among Streptococcus pneumoniae serotype 19A isolates from 10 Asian countries. J. Antimicrob. Chemoter., 66:1001–1004.
21.
SiiraL., JalavaJ., TissariP., VaaraM., KaijalainenT., and VirolainenA.2012. Clonality behaind the increase of multidrug-resistance among non-invasive pneumococci in Southern Finland. Eur. J. Clin. Microbiol. Infect. Dis., 31:867–871.
22.
SongJ.-H., DaganR., KlugmanK.P., and FritzellB.. 2012. The relationship between pneumococcal serotypes and antibiotic resistance. Vaccine, 30:2728–2737.
23.
SorensenU.B.S.1993. Typing of pneumococci by using 12 pooled antisera. J. Clin. Microbiol., 31:2097–2100.
24.
SutcliffeJ., GrebeT., Tait-KamradtA., and WondrackL.1996. Detection of erythromycin-resistant determinants by PCR. Antimicrob. Agents Chemother., 40:2562–2566.
25.
Tait-KamradtA., DaviesT., AppelbaumP.C., DepardieuF., CourvalinP., PetitpasJ., WondrackL., WalkerA., JacobsM.R., and SutcliffeJ.. 2000. Two new mechanisms of macrolide resistance in clinical strains of Streptococcus pneumoniae from Eastern Europe and North America. Antimicrob. Agents Chemother., 44:3395–3401.
26.
TenoverF.C., ArbeitR.D., GoeringR.V., MickelsenP.A., MurrayB.E., PersingD.H., and SwaminathanB.. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol., 33:2233–2239.
27.
Van der LindenM., ReinertR.R., KernW.V., and ImöhlM.. 2012. Epidemiology of serotype 19A isolates from invasive pneumococcal disease in German children. BMC Infect. Dis., 13:70.
28.
World Health Organization. 2012. Pneumococcal vaccines—WHO position paper. Wkly. Epidemiol. Rec., 87:129–144.
